Vetigenics
Vetigenics is a clinical-stage animal health biotechnology company developing antibody therapeutics for pets. Their proprietary CANIBODY technology enables faster and more cost-effective antibody development, targeting unmet needs in treating canine cancers and other pet diseases like autoimmune disorders, obesity, and allergies.
Funding Round: Seed
Funding Amount: $6M
Date: 03-Feb-2025
Investors:
Markets: Animal Health, Biotech, Therapeutics
HQ: Philadelphia, Pennsylvania, United States
Founded: 2017
Website: http://www.vetigenics.com/
LinkedIn: https://www.linkedin.com/company/vetigenics
Crunchbase: https://www.crunchbase.com/organization/vetigenics
Leave a Comment
Comments
No comments yet.